stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Edgewise Therapeutics IncEWTX
$38.280.45%0.17

Edgewise Therapeutics Inc (EWTX)

Date: 2026-11-03 16:00O: 38.73H: 40.41L: 36.70C: 38.25Vol: 1.039M
Precedente Chiudi:
$38.11
Aprire:
$38.73
Volume 24 ore:
1,044,112
Volume relativo:
0.80
Capitalizzazione di mercato:
$4.16B
Reddito:
-
Utile/perdita netta:
-$176.01M
Rapporto P/E:
-
EPS:
-$1.66
Flusso di cassa netto:
-$148.97M
1W Prestazione:
-3.16%
1M Prestazione:
-7.54%
6M Prestazione:
+25.06%
1Y Prestazione:
+113.02%
Intervallo 1D:
$36.70$40.41
Intervallo di 1 settimana:
$37.46$41.63
Portata 52W:
$16.70$48.51

Profilo aziendale di Edgewise Therapeutics Inc (EWTX)

Nome
Edgewise Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER, USA
Dipendente
146
X
-
Prossima data di guadagno
2026-11-05
Ultimi documenti SEC
SEC
Discussioni di EWTX su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Edgewise Therapeutics Inc Azioni (EWTX) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-16IniziatoWilliam BlairOutperform
2026-07-09IniziatoOppenheimerOutperform
2025-09-25IniziatoGoldmanNeutral
2025-07-30IniziatoRaymond JamesStrong Buy

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)151.39126.9790.9154.0332.19
Operating expenses USD (M)191.41158.83114.3671.6643.22
Operating income USD (M)-191.41-158.83-114.36-71.66-43.22
Income before tax USD (M)-167.80--100.16-67.64-42.81
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-167.80-133.81-100.16-67.64-42.81
Basic EPS USD/shares-1.63-1.45-1.57-1.26-1.14
Diluted EPS USD/shares-1.63-1.45-1.57-1.26-1.14
Basic weighted shares shares (M)102.9392.4163.7253.5937.53
Diluted weighted shares shares (M)102.9392.4163.7253.5937.53

Edgewise Therapeutics Inc Azioni (EWTX) insider trading

  • JOANNE DONOVANAug 13 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $43.56
    #Azioni
    2,919
    Valore ($)
    127,152
    #Azioni Totale
    0
  • CMO
    Transazione
    Sale
    Costo
    $43.41
    #Azioni
    2,919
    Valore ($)
    126,704
    #Azioni Totale
    8,625
  • MOORE JOHN RAug 12 '26
    General Counsel
    Transazione
    Sale
    Costo
    $43.82
    #Azioni
    5,016
    Valore ($)
    219,823
    #Azioni Totale
    17,697
  • Chief Business Officer
    Transazione
    Option Exercise
    Costo
    $0.00
    #Azioni
    13,281
    Valore ($)
    0
    #Azioni Totale
    36,926
  • Chief Business Officer
    Transazione
    Sale
    Costo
    $43.81
    #Azioni
    5,100
    Valore ($)
    223,424
    #Azioni Totale
    31,826
  • KOCH KEVINAug 12 '26
    President and CEO
    Transazione
    Option Exercise
    Costo
    $0.00
    #Azioni
    39,844
    Valore ($)
    0
    #Azioni Totale
    70,459
  • KOCH KEVINAug 12 '26
    President and CEO
    Transazione
    Sale
    Costo
    $43.68
    #Azioni
    17,971
    Valore ($)
    785,042
    #Azioni Totale
    52,488
  • Russell Alan JAug 12 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $43.73
    #Azioni
    5,901
    Valore ($)
    258,042
    #Azioni Totale
    31,466
  • MOORE JOHN RAug 12 '26
    General Counsel
    Transazione
    Option Exercise
    Costo
    $0.00
    #Azioni
    12,499
    Valore ($)
    0
    #Azioni Totale
    22,713
  • CMO
    Transazione
    Sale
    Costo
    $43.85
    #Azioni
    6,522
    Valore ($)
    286,000
    #Azioni Totale
    11,544
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
JOANNE DONOVANOfficerAug 13 '26Proposed Sale$43.562,919127,1520
Donovan Joanne M.CMOAug 13 '26Sale$43.412,919126,7048,625
MOORE JOHN RGeneral CounselAug 12 '26Sale$43.825,016219,82317,697
Derakhshan BehradChief Business OfficerAug 12 '26Option Exercise$0.0013,281036,926
Derakhshan BehradChief Business OfficerAug 12 '26Sale$43.815,100223,42431,826
KOCH KEVINPresident and CEOAug 12 '26Option Exercise$0.0039,844070,459
KOCH KEVINPresident and CEOAug 12 '26Sale$43.6817,971785,04252,488
Russell Alan JChief Scientific OfficerAug 12 '26Sale$43.735,901258,04231,466
MOORE JOHN RGeneral CounselAug 12 '26Option Exercise$0.0012,499022,713
Donovan Joanne M.CMOAug 12 '26Sale$43.856,522286,00011,544

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Apr 01, 2026
Apr 01, 2026
Sep 23, 2026
Sep 23, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 22, 2026
Sep 22, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 04, 2026
Sep 04, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 01, 2026
Sep 01, 2026
Aug 31, 2026
Aug 31, 2026
Aug 24, 2026
Aug 24, 2026
Aug 23, 2026
Aug 23, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 16, 2026
Aug 16, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026

Simile a EWTX